Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin-Reference-Cited by-同舟云学术

Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin

Published:2022-02 Issue:5 Volume:79 Page:432-444
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Vaduganathan Muthiah,Sattar Naveed,Xu Jialin,Butler Javed,Mahaffey Kenneth W.,Neal Bruce,Shaw Wayne,Rosenthal Norman,Pfeifer Michael,Hansen Michael K.,Januzzi James L.

Funder

Pfizer

Singulex

Baxter Healthcare Corporation

AstraZeneca

Novo Nordisk

Novartis Pharmaceuticals Corporation

Merck

Janssen Pharmaceuticals

Novartis

Merck Sharp and Dohme

Eli Lilly and Company

Cytokinetics

AbbVie

Abbott Laboratories

Amgen

Boehringer Ingelheim

Roche

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials;Zelniker;Lancet,2019

2. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis;Neuen;Lancet. Diabetes Endocrinol,2019

3. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials;Zannad;Lancet,2020

4. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2021.;Diabetes Care,2021

5. Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes;Pandey;J Am Coll Cardiol HF,2021

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart Failure;Biomedicines;2024-08-12

2. Effect of hyperglycemia and empagliflozin on markers of cardiorenal injury and inflammation in patients with type 1 diabetes;Diabetes Research and Clinical Practice;2024-07

3. Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study;Cardiovascular Research;2024-04-13

4. Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS;Diabetes, Obesity and Metabolism;2024-04-08

5. Insulin‐like growth factor binding protein‐7 concentrations in chronic heart failure: Results from the EMPEROR programme;European Journal of Heart Failure;2024-04